IADR and GlaxoSmithKline Consumer Healthcare announ...(ffer from oral and systemic diseases to ...),Health
ffer from oral and systemic diseases to be notified sooner and receive the most informative diagnostics.
This year, the IADR/GSK Innovation in Oral Care Awards received 35 applications from teams of researchers from around the globe. Each application was reviewed by a panel of experts under the chairmanship of Dr. Mariano Sanz, Dean, Universidad Complutense de Madrid Dental School.
The awards will be presented during the 86th General Session & Exhibition of the IADR, to be held July 2-5, 2008, in Toronto, Ontario, Canada.
GlaxoSmithKline is privileged to work with the IADR in providing the Innovation in Oral Care Awards to help such talented teams of researchers develop new treatments and products, said Dr. David Alexander, Director of Global Dental Professional Relations for GlaxoSmithKline Consumer Healthcare. The IADR membership comprises some of the most innovative scientists and clinicians in the field of oral health. All three winning entries address very significant quality-of-life issues, and GSK hopes that these innovative concepts will one day be widely available as new products to improve the lives of those suffering from disease.
On behalf of the IADR, I thank GSK and Dr. David Alexander for making possible this unique and prestigious award program, said IADR President Deborah Greenspan. Under the excellent direction of Dr. Mariano Sanz, the committee reviewed many outstanding research projects, and we are pleased that the winning projects fit the key criterion for this award, namely, the potential of the proposed research for translation to publicly available and cost-effective therapies in the medium term.
In this the fifth year of these awards, the grant from GSK has supported 13 teams from the United States, Northern Ireland,
Scotland, Hong Kong, Israel and Iceland with over $1 million to further their research. In addition, applications have been
received from over 190 teams of researchers
'/>"/>
| Contact: Denise Streszoff dstreszoff@iadr.org 703-299-8087 International & American Association for Dental Research Source:Eurekalert |
Related medicine news :
1. A Statement from GlaxoSmithKline Consumer Healthcare on 2008 Update to the U.S. Public Health Service Guideline on Treating Tobacco Use and Dependence
2. Concern From Doctors Regarding the Cardiovascular Safety of GlaxoSmithKlines Avandia Increases Nine-Fold Following Publication of Meta-Analysis
3. GlaxoSmithKline Confirms Receipt of FDA Letter on Regulatory Reporting
4. Astellas/GlaxoSmithKlines Vesicare Has Advantages Over Pfizers Detrol LA/Detrusitol XL in Reducing Episodes of Urge Urinary Incontinence
5. GlaxoSmithKline Awards Eight Area Healthcare Nonprofits with $40,000 Each in Funding
6. EUSA Pharma Out-Licenses Preclinical-Stage Human Antibody to GlaxoSmithKline for up to $44 Million Plus Royalties
7. Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program
8. AUDIO from Medialink and GlaxoSmithKline: Get Ready to Get Moving to a New You in the New Year
9. Audio from Medialink and GlaxoSmithKline: Cleaning House ... Overhaul Your Fridge and Pantry to Lose Weight
10. VIDEO from Medialink and GlaxoSmithKline: Really Think You Can Lose 30 Pounds in 30 Days?
11. AUDIO from Medialink and GlaxoSmithKline: Setting Realistic Goals for a New You in the New Year
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |